Clinical trial Recruiting at 1 site Interventional Ages 18 to 35 Women only

Leg vs Arm Ergometer Exercise for Gestational Diabetes

Official title: Effects of Leg Ergometer Versus Arm Ergometer on Blood Glucose, Exercise Tolerance, Weight, and Psychological Stress Among Gestational Diabetic Patients

Run by Lahore University of Biological and Applied Sciences · NCT07554287 · Data updated 2026-11-12

This study tests whether leg-ergometer exercise helps control blood sugar and reduce stress more than arm-ergometer exercise in pregnant people with gestational diabetes.

Quick facts

Study typeInterventional
Ages18 Years to 35 Years
SexWomen only
Enrollment108 (estimated)
SponsorLahore University of Biological and Applied Sciences
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedMay 26, 2026
Main results expectedSeptember 26, 2026
Study endsOctober 15, 2026
Registry record updatedJune 18, 2026
Trial IDNCT07554287 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18-35 with gestational diabetes in the second trimester (14-28 weeks), singleton pregnancy, and cleared for moderate aerobic exercise.

Probably not a fit

Participants with uncontrolled hypertension, overt diabetes, or contraindications to aerobic exercise may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, single-blind trial compares leg and arm ergometer exercise added to standard care in pregnant women with gestational diabetes. Eight weeks of supervised sessions, 20-30 minutes, three times weekly at moderate intensity, will measure glucose, exercise tolerance, weight, and psychological stress. Participants are 18-35 years old, in the second trimester, with singleton pregnancies and no overt diabetes or hypertension, recruited from hospitals in Lahore. The study aims to determine if leg-based aerobic exercise provides greater metabolic and psychosocial benefits than arm-based aerobic exercise during pregnancy.

Why it matters

Potential benefit: If successful, leg ergometer exercise could offer a more effective non-pharmacologic option to improve glycemic control and well-being in gestational diabetes.

How similar studies have gone: Evidence in similar athletic-therapy contexts supports aerobic exercise in GDM, but direct leg vs arm ergometer comparisons are limited, making this approach relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Female participants aged 18-35 years.
2. Gestational age 14-28 weeks (second trimester).
3. Singleton pregnancy (confirmed by obstetric record) only to avoid complications of multiple gestation.
4. Include both primigravida and multigravida (i.e., first or subsequent pregnancy).
5. Women with first time GDM in pregnancy.
6. Women with clinical diagnosis of gestational diabetes according to hospital/WHO criteria or hospital diagnostic test.
7. Blood glucose levels:

   Random capillary glucose \< 200 mg/dL at screening (to exclude overt diabetes)
8. Blood pressure:

   * Systolic BP \< 140 mmHg and Diastolic BP \< 90 mmHg (no confirmed gestational hypertension).
   * If BP ≥140/90 mmHg, confirm with repeat measurement 4 hours apart; exclude if persistent.
9. Willingness to participate and provide written informed consent.
10. Medically cleared by obstetrician to participate in moderate aerobic exercise.

Exclusion Criteria:

1. Previous Cesarean section or medically indicated bed rest.
2. Known pre-existing diabetes mellitus (Type 1 or Type 2 prior to pregnancy).
3. Known major obstetric complications (e.g., placenta previa, severe pre- eclampsia).
4. Patients having multiple/twin/triplet pregnancies.
5. Known major fetal anomaly.
6. Anemic women with Hb \< 9 g/dL (excluded to prevent exercise intolerance).
7. Uncontrolled cardiovascular disease, musculoskeletal, or medical contraindications to exercise.
8. Psychiatric conditions severe enough to hinder informed consent.
9. Any other medical condition that, in the opinion of the obstetrician, makes participation unsafe.

Where it's running

  • Jinnah Hospital
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.